tirzepatide death Treatment with #tirzepatide in the SUMMIT trial led to a lower risk of from cardiovascular causes or worsening heart failure and improved health status in patients with #HFpEF and obesity. https://t.co/O9iU9a1Xgw Wegovy cuts risk of heart

GLP-1 medications can actually increase some womens chances of getting pregnant

Ultimately, genediseasedrug models, supported by integrative resources like GeneDive and other PGx knowledge bases, can drive precision prescribing of dual GIP/GLP-1 agonists, matching patients to the greatest achievable metabolic and cardiovascular advantage [86]

Various mechanisms have been theorized to describe how dual agonism, as GLP-1 RA, could directly reduce triglycerides hepatocyte storage, lipogenesis and improving hepatic glucose metabolism (96) and promoting lipolysis and fatty acid oxidation (97)

Others may have a slower metabolism due to genetic factors

Neurology , 65 (4), 580585